Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Buy
68
MCBI Quote, Financials, Valuation and Earnings
Last price:
$23.50
Seasonality move
:
9.3%
Day range:
$23.50 - $23.51
52-week range:
$19.02 - $24.50
Dividend yield:
1.11%
P/E ratio:
13.20x
P/S ratio:
1.55x
P/B ratio:
1.03x
Volume:
400
Avg. volume:
12.9K
1-year change:
9.3%
Market cap:
$149.6M
Revenue:
$95.2M
EPS (TTM):
$1.78
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $50M | $61.5M | $83.5M | $94.8M | $95.2M | |
| Revenue Growth (YoY) | 8.21% | 22.89% | 35.89% | 13.47% | 0.38% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $76K | -$1.7M | -$1.5M | -- | -- | |
| Operating Expenses | -$30.4M | -$23.8M | -$8.7M | -$11.5M | -$14.3M | |
| Operating Income | $30.4M | $23.8M | $8.7M | $11.5M | $14.3M | |
| Net Interest Expenses | $1.5M | $2.6M | $8.5M | $5.6M | $3.6M | |
| EBT. Incl. Unusual Items | $30.4M | $23.8M | $8.7M | $11.5M | $14M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.7M | $5.4M | $1.8M | $2.6M | $2.8M | |
| Net Income to Company | $23.6M | $18.4M | $6.9M | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $23.6M | $18.4M | $6.9M | $8.9M | $11.2M | |
| Basic EPS (Cont. Ops) | $3.78 | $2.97 | $1.11 | $1.42 | $1.78 | |
| Diluted EPS (Cont. Ops) | $3.78 | $2.96 | $1.11 | $1.42 | $1.78 | |
| Weighted Average Basic Share | $6.2M | $6.2M | $6.2M | $6.3M | $6.3M | |
| Weighted Average Diluted Share | $6.3M | $6.2M | $6.2M | $6.3M | $6.3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $34.3M | $34.5M | $58.2M | $72.1M | $66.9M | |
| Revenue (Reported) | $50M | $61.5M | $83.5M | $94.8M | $95.2M | |
| Operating Income (Reported) | $30.4M | $23.8M | $8.7M | $11.5M | $14.3M | |
| Operating Income (Adjusted) | $34.3M | $34.5M | $58.2M | $72.1M | $66.9M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $13.1M | $17.8M | $22.2M | $23.9M | $23.8M | |
| Revenue Growth (YoY) | 8.67% | 35.86% | 24.27% | 7.87% | -0.36% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $7K | -$330K | -$757K | -- | -- | |
| Operating Expenses | -$6.1M | -$4.9M | $144K | -$3M | -$3.2M | |
| Operating Income | $6.1M | $4.9M | -$144K | $3M | $3.2M | |
| Net Interest Expenses | $299K | $1.2M | $2.2M | $1.2M | $801K | |
| EBT. Incl. Unusual Items | $6.1M | $4.9M | -$200K | $3M | $3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $994K | $1.1M | $176K | $869K | $677K | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $5.1M | $3.8M | -$376K | $2.1M | $2.3M | |
| Basic EPS (Cont. Ops) | $0.81 | $0.61 | -$0.06 | $0.33 | $0.37 | |
| Diluted EPS (Cont. Ops) | $0.81 | $0.61 | -$0.06 | $0.33 | $0.37 | |
| Weighted Average Basic Share | $6.2M | $6.2M | $6.3M | $6.3M | $6.3M | |
| Weighted Average Diluted Share | $6.2M | $6.2M | $6.3M | $6.3M | $6.3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $6.9M | $11M | $14.2M | $17.2M | $15.8M | |
| Revenue (Reported) | $13.1M | $17.8M | $22.2M | $23.9M | $23.8M | |
| Operating Income (Reported) | $6.1M | $4.9M | -$144K | $3M | $3.2M | |
| Operating Income (Adjusted) | $6.9M | $11M | $14.2M | $17.2M | $15.8M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $50M | $61.4M | $84.7M | $94.9M | $95.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $76K | -$1.7M | -$1.5M | -- | -- | |
| Operating Expenses | -$30.4M | -$23.8M | -$9M | -$11.5M | -$14.3M | |
| Operating Income | $30.4M | $23.8M | $9M | $11.5M | $14.3M | |
| Net Interest Expenses | $1.5M | $2.6M | $8.5M | $5.6M | $3.6M | |
| EBT. Incl. Unusual Items | $30.4M | $23.8M | $8.7M | $11.5M | $14M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.7M | $5.4M | $1.8M | $2.6M | $2.8M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $23.6M | $18.4M | $6.9M | $8.9M | $11.2M | |
| Basic EPS (Cont. Ops) | $3.77 | $2.97 | $1.11 | $1.42 | $1.79 | |
| Diluted EPS (Cont. Ops) | $3.77 | $2.96 | $1.11 | $1.42 | $1.78 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $34.3M | $34.5M | $58.2M | $72.1M | $66.9M | |
| Revenue (Reported) | $50M | $61.4M | $84.7M | $94.9M | $95.2M | |
| Operating Income (Reported) | $30.4M | $23.8M | $9M | $11.5M | $14.3M | |
| Operating Income (Adjusted) | $34.3M | $34.5M | $58.2M | $72.1M | $66.9M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $61.4M | $84.7M | $94.9M | $95.2M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$1.7M | -$1.5M | $99K | -$157K | -- | |
| Operating Expenses | -$23.8M | -$9M | -$11.5M | -$14.3M | -- | |
| Operating Income | $23.8M | $9M | $11.5M | $14.3M | -- | |
| Net Interest Expenses | $2.6M | $8.5M | $5.6M | $3.6M | -- | |
| EBT. Incl. Unusual Items | $23.8M | $8.7M | $11.5M | $14M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $5.4M | $1.8M | $2.6M | $2.8M | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $18.4M | $6.9M | $8.9M | $11.2M | -- | |
| Basic EPS (Cont. Ops) | $2.97 | $1.11 | $1.42 | $1.79 | -- | |
| Diluted EPS (Cont. Ops) | $2.96 | $1.11 | $1.42 | $1.78 | -- | |
| Weighted Average Basic Share | $24.8M | $24.9M | $25.1M | $25.1M | -- | |
| Weighted Average Diluted Share | $24.9M | $25M | $25.1M | $25.1M | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $34.5M | $58.2M | $72.1M | $66.9M | -- | |
| Revenue (Reported) | $61.4M | $84.7M | $94.9M | $95.2M | -- | |
| Operating Income (Reported) | $23.8M | $9M | $11.5M | $14.3M | -- | |
| Operating Income (Adjusted) | $34.5M | $58.2M | $72.1M | $66.9M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $10.7M | $13.8M | $21.2M | $15.8M | $14.7M | |
| Short Term Investments | $155.9M | $137.4M | $130.2M | -- | -- | |
| Accounts Receivable, Net | $3.4M | $4.5M | $5.5M | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $72.3M | $87.4M | $78.1M | $87.5M | $92.2M | |
| Property Plant And Equipment | $19.3M | $35.7M | $54.4M | $62.5M | $59.3M | |
| Long-Term Investments | $64.5M | $72M | $55.8M | $64M | $68.8M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.3B | $1.6B | $1.7B | $1.7B | $1.8B | |
| Accounts Payable | $398K | $885K | $2.3M | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $829.6M | $1B | $1.2B | $1.2B | $861.3M | |
| Long-Term Debt | $21.4M | $21.9M | $31.6M | $35.1M | $18M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.2B | $1.5B | $1.6B | $1.6B | $1.6B | |
| Common Stock | $62.9K | $64K | $64K | $64K | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $121.1M | $117.3M | $122.8M | $132.4M | $145.6M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $121.1M | $117.3M | $122.8M | $132.4M | $145.6M | |
| Total Liabilities and Equity | $1.3B | $1.6B | $1.7B | $1.7B | $1.8B | |
| Cash and Short Terms | $224.8M | $216.1M | $199.1M | -- | -- | |
| Total Debt | $23.4M | $21.9M | $31.6M | $35.1M | $18M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $10.7M | $13.8M | $21.2M | $15.8M | $14.7M | |
| Short Term Investments | $155.9M | $137.4M | $130.2M | -- | -- | |
| Accounts Receivable, Net | $3.4M | $4.5M | $5.5M | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $72.3M | $87.4M | $78.1M | $87.5M | $92.2M | |
| Property Plant And Equipment | $19.3M | $35.7M | $54.4M | $62.5M | $59.3M | |
| Long-Term Investments | $64.5M | $72M | $55.8M | $64M | $68.8M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.3B | $1.6B | $1.7B | $1.7B | $1.8B | |
| Accounts Payable | $398K | $885K | $2.3M | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $829.6M | $1B | $1.2B | $1.2B | $861.3M | |
| Long-Term Debt | $21.4M | $21.9M | $31.6M | $35.1M | $18M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.2B | $1.5B | $1.6B | $1.6B | $1.6B | |
| Common Stock | $62.9K | $64K | $64K | $64K | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $121.1M | $117.3M | $122.8M | $132.4M | $145.6M | |
| Total Liabilities and Equity | $1.3B | $1.6B | $1.7B | $1.7B | $1.8B | |
| Cash and Short Terms | $224.8M | $216.1M | $199.1M | -- | -- | |
| Total Debt | $23.4M | $21.9M | $31.6M | $35.1M | $18M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $10.2M | $23.6M | $18.4M | $6.9M | -- | |
| Depreciation & Amoritzation | $518.4K | $488.4K | $585K | $1.1M | $1.9M | |
| Stock-Based Compensation | $387.3K | $479.3K | $915K | $1.2M | $1.1M | |
| Change in Accounts Receivable | -$1.6M | $852K | -$1.1M | -$1.1M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $19.6M | $22.4M | $23.4M | $8.3M | $10.4M | |
| Capital Expenditures | $987K | $8.3M | $20.6M | $19.5M | $10.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$148.1M | -$231.8M | -$276.4M | -$144.3M | -$860K | |
| Dividends Paid (Ex Special Dividend) | -- | $3.3M | $3.9M | $4.1M | $1.5M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $308M | $200M | $1.2B | $1.5B | -- | |
| Long-Term Debt Repaid | -$285M | -$177M | -$1.1B | -$1.5B | -- | |
| Repurchase of Common Stock | -- | $2.3M | $16K | $217K | $94K | |
| Other Financing Activities | -$245.5K | -- | -$16K | -$4K | -- | |
| Cash From Financing | $186.7M | $203.3M | $262.8M | $126.2M | -$2.9M | |
| Beginning Cash (CF) | $16.6M | $74.9M | $68.9M | $78.6M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $58.3M | -$6M | $9.8M | -$9.8M | $6.7M | |
| Ending Cash (CF) | $74.9M | $68.9M | $78.6M | $68.9M | -- | |
| Levered Free Cash Flow | $18.7M | $14.2M | $2.8M | -$11.2M | $135K | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2022-01-27 | 2023-01-27 | 2024-01-27 | 2025-01-27 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get MCBI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MCBI
Sector
P/E ratio
13.20x
12.22x
PEG ratio
0.52x
0.31x
P/B ratio
1.03x
1.11x
Price / LTM sales
1.55x
1.83x
Growth Metrics
MCBI
Sector
Revenue growth
-0.36%
5.22%
Earnings growth
10.36%
14.16%
Revenue (5-year growth)
15.53%
8.83%
Earnings forecast
$0.38
$0.63
Profitability
MCBI
Sector
Profitability FY 2025
--
--
Return on invested capital
5.36%
5.04%
Return on assets
0.63%
1.01%
Return on equity
8.04%
9.76%
Earnings Date
Last Earnings Date
Feb
7
Next Earnings Date
Jan
27
Estimated Next Earnings Date
Apr
28
Balance Sheet
MCBI
Sector
Total cash
$234.3M
$412.1M
Short term investments
$130.2M
$193.9M
Total assets
$1.8B
$3.1B
Long term debt
$18M
$73.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Is Palantir Stock Going to Crash?
AI and data analytics major Palantir (NASDAQ:PLTR) has become something…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
73
BNAI alert for Jan 27
Brand Engagement Network, Inc. [BNAI] is down 16.56% over the past day.
Buy
52
CVLT alert for Jan 27
Commvault Systems, Inc. [CVLT] is down 33.09% over the past day.
Sell
48
RVMD alert for Jan 27
Revolution Medicines, Inc. [RVMD] is up 2.49% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
